Tuberculosis

Reaching Further, Faster with Critical Tuberculosis Treatment in India

Treating tuberculosis in any country presents challenges: the highly infectious disease takes on many forms — pulmonary, renal, even ocular — that make it difficult to diagnose, especially in children. Any interruption to the months-long treatment course often results in […]

Treating tuberculosis in any country presents challenges: the highly infectious disease takes on many forms — pulmonary, renal, even ocular — that make it difficult to diagnose, especially in children. Any interruption to the months-long treatment course often results in a drug-resistant strain and ongoing disease transmission, complicating efforts to eradicate the disease.

But addressing tuberculosis is especially difficult in a country with more than 2 million cases annually, dense population clusters and widespread health inequity. The Indian government’s goal of eliminating tuberculosis requires more healthcare providers than ever before to be trained in tuberculosis diagnosis, referral, and treatment, which would take immense resources relying on solely in-person training travel costs and resources.

In order to begin to meaningfully decrease tuberculosis, ECHO India and India’s Ministry of Health and Family Welfare have partnered to use the ECHO Model’s case presentations, virtual communities of practice, and telementoring expertise to train thousands of health care providers across the country to provide full treatment to patients.

At ECHO sessions, health care workers in the most rural parts of the country have a chance to consult experts on best-practice tuberculosis care.

ECHO India is a nonprofit trust established in 2008 in partnership with Project ECHO, using the ECHO Model to reach all corners of the world’s most populous country. After successfully launching an ECHO program treating hepatitis C in 22 district hospitals and two medical colleges in the state of Punjab, ECHO India leveraged their existing infrastructure and relationships with hospitals to test out a pilot for something new: countrywide tuberculosis training. When a preliminary tuberculosis program, with interventions shared in monthly and twice-per-month ECHO sessions, showed treatment times were reduced by two weeks, ECHO India received funding from the Center for Disease Control and PATH, a non-profit focused on global research, to expand tuberculosis programs from five Hubs in 2018 to 40 Hubs by early 2020.

To date, 29,000 health care providers have now been trained and mentored on best practices for complex diagnosis, treatment, and referral. Across all 36 statesECHO India is reaching more rural providers, female providers, and providers from different facets of the health care system, Babu Ramachandran, the project manager for tuberculosis at ECHO India, explains.

“India’s widespread tuberculosis ECHO network grew out of other programs. People, especially in rural areas, are really excited to have a place to discuss clinical questions with experts. Traditionally, providers have to rely on their prior in-person training only,” says Ramachandran.

As Dr. Sumalata Chittiboyina, a tuberculosis epidemiologist with more than 20 years of experience working in the southern capital city of Hyderabad, adds, “The ECHO Model’s impact goes far beyond physicians. The deeper problem with tuberculosis in India is that it is a lot of work to track cases and potential contacts. People travel, they do not have access to care always, they get too busy for treatment. All of those things can cause people to not complete their treatment.

With ECHO, we are able to train field staff on their smaller day-to-day challenges of helping people access and complete treatment, which is what we need to do at scale to really make a difference.

Tuberculosis specialists based in New Delhi hospitals joined an ECHO session with providers from across the country.

One of those challenging cases was an 11-year-old girl who had developed a type of tuberculosis that did not respond to the typical medications.

“Pediatric cases, especially those with drug resistance, are difficult to treat because the amount and timing of medication is so different than with adults,” notes Dr. Chittiboyina. “Together on our ECHO sessions, we worked to find a treatment that worked for her, and to make sure she could fully complete treatment, since that is what had caused her drug resistance.”

Applying the ECHO Model to decrease India’s rate of tuberculosis demonstrates the strengths of the ECHO movement: collaboration between local and global experts, adapting virtual communities of practice to meet dynamic local resources and contexts, and establishing solutions that create health equity for the long-term.

Share this story:

Media Contact:

Ben Cloutier
Director of Communications & Marketing
Project ECHO
(505) 252-4157
BeCloutier@salud.unm.edu